The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Fampridine Rowa 10 mg prolonged-release tablets

Rowa Pharmaceuticals LimitedPA0074/087/001

Main Information

Trade NameFampridine Rowa 10 mg prolonged-release tablets
Active SubstancesFampridine
Dosage FormProlonged-release tablet
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/087/001

Group Information

ATC CodeN07XX07 fampridine


License statusAuthorised
Licence Issued01/07/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceSubject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back